The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.

This study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Share on Pinterest A new study shows GLP-1 drugs liraglutide ... Wegovy is approved for use in weight management. Semaglutide drugs are available as both oral tablets and injections.

That's according to the study funded by ... taking semaglutide. The GLP-1 drugs have become increasingly popular, with at least 1 in 8 U.S. adults reporting their use, according to a 2024 survey ...

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs receive a prescription for it, according to a new study from ... like peptide-1 (GLP-1) agonists are ...

lower-dose care model to U.S. employers seeking sustainability As GLP-1 adoption grows among U.S. employers, the study points to a path toward meaningful outcomes without escalating drug costs.